科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/27 | 3,580 | 3,605 | 3,545 | 3,580 | +5 | +0.1% | 77,200 |
| 2022/05/26 | 3,555 | 3,595 | 3,555 | 3,575 | +5 | +0.1% | 61,800 |
| 2022/05/25 | 3,585 | 3,620 | 3,570 | 3,570 | -25 | -0.7% | 87,400 |
| 2022/05/24 | 3,650 | 3,650 | 3,590 | 3,595 | -70 | -1.9% | 41,900 |
| 2022/05/23 | 3,620 | 3,680 | 3,605 | 3,665 | +80 | +2.2% | 78,700 |
| 2022/05/20 | 3,655 | 3,655 | 3,580 | 3,585 | -55 | -1.5% | 104,900 |
| 2022/05/19 | 3,610 | 3,660 | 3,610 | 3,640 | -90 | -2.4% | 62,700 |
| 2022/05/18 | 3,735 | 3,750 | 3,710 | 3,730 | -15 | -0.4% | 55,600 |
| 2022/05/17 | 3,765 | 3,805 | 3,745 | 3,745 | +10 | +0.3% | 40,300 |
| 2022/05/16 | 3,840 | 3,840 | 3,730 | 3,735 | -70 | -1.8% | 59,300 |
| 2022/05/13 | 3,725 | 3,805 | 3,680 | 3,805 | +75 | +2% | 66,900 |
| 2022/05/12 | 3,845 | 3,845 | 3,730 | 3,730 | -125 | -3.2% | 99,800 |
| 2022/05/11 | 3,930 | 3,975 | 3,815 | 3,855 | -80 | -2% | 117,000 |
| 2022/05/10 | 3,955 | 3,970 | 3,925 | 3,935 | -5 | -0.1% | 76,400 |
| 2022/05/09 | 3,965 | 3,980 | 3,930 | 3,940 | -30 | -0.8% | 69,100 |
| 2022/05/06 | 3,950 | 3,990 | 3,925 | 3,970 | +20 | +0.5% | 75,400 |
| 2022/05/02 | 3,935 | 3,970 | 3,915 | 3,950 | +15 | +0.4% | 51,800 |
| 2022/04/28 | 3,825 | 3,945 | 3,810 | 3,935 | +125 | +3.3% | 94,900 |
| 2022/04/27 | 3,830 | 3,850 | 3,785 | 3,810 | -40 | -1% | 132,100 |
| 2022/04/26 | 3,860 | 3,885 | 3,845 | 3,850 | ±0 | ±0% | 58,800 |
| 2022/04/25 | 3,835 | 3,865 | 3,820 | 3,850 | -15 | -0.4% | 63,900 |
| 2022/04/22 | 3,845 | 3,880 | 3,840 | 3,865 | -10 | -0.3% | 43,300 |
| 2022/04/21 | 3,850 | 3,890 | 3,850 | 3,875 | +55 | +1.4% | 54,700 |
| 2022/04/20 | 3,820 | 3,835 | 3,790 | 3,820 | +15 | +0.4% | 60,600 |
| 2022/04/19 | 3,810 | 3,815 | 3,775 | 3,805 | +10 | +0.3% | 63,800 |
| 2022/04/18 | 3,800 | 3,805 | 3,760 | 3,795 | -30 | -0.8% | 107,900 |
| 2022/04/15 | 3,870 | 3,885 | 3,815 | 3,825 | -70 | -1.8% | 83,900 |
| 2022/04/14 | 3,880 | 3,905 | 3,875 | 3,895 | ±0 | ±0% | 58,100 |
| 2022/04/13 | 3,895 | 3,915 | 3,870 | 3,895 | ±0 | ±0% | 64,600 |
| 2022/04/12 | 3,945 | 3,950 | 3,895 | 3,895 | -40 | -1% | 68,200 |
| 2022/04/11 | 3,930 | 3,950 | 3,910 | 3,935 | ±0 | ±0% | 79,200 |
| 2022/04/08 | 3,985 | 3,990 | 3,910 | 3,935 | +5 | +0.1% | 93,600 |
| 2022/04/07 | 3,890 | 3,945 | 3,870 | 3,930 | +30 | +0.8% | 124,500 |
| 2022/04/06 | 3,945 | 3,955 | 3,885 | 3,900 | -25 | -0.6% | 148,800 |
| 2022/04/05 | 3,975 | 3,975 | 3,915 | 3,925 | ±0 | ±0% | 67,300 |
| 2022/04/04 | 3,955 | 3,955 | 3,920 | 3,925 | +10 | +0.3% | 52,700 |
| 2022/04/01 | 3,890 | 3,935 | 3,870 | 3,915 | +25 | +0.6% | 106,700 |
| 2022/03/31 | 3,935 | 3,945 | 3,880 | 3,890 | -55 | -1.4% | 130,900 |
| 2022/03/30 | 3,945 | 3,965 | 3,900 | 3,945 | -120 | -3% | 181,400 |
| 2022/03/29 | 4,065 | 4,070 | 4,005 | 4,065 | +10 | +0.2% | 88,700 |
| 2022/03/28 | 4,060 | 4,080 | 4,025 | 4,055 | +35 | +0.9% | 82,600 |
| 2022/03/25 | 3,990 | 4,020 | 3,965 | 4,020 | +60 | +1.5% | 136,800 |
| 2022/03/24 | 3,990 | 4,025 | 3,935 | 3,960 | -80 | -2% | 154,800 |
| 2022/03/23 | 3,960 | 4,045 | 3,940 | 4,040 | +100 | +2.5% | 173,900 |
| 2022/03/22 | 3,955 | 3,990 | 3,880 | 3,940 | +5 | +0.1% | 314,000 |
| 2022/03/18 | 4,180 | 4,180 | 3,935 | 3,935 | -260 | -6.2% | 189,700 |
| 2022/03/17 | 4,270 | 4,270 | 4,180 | 4,195 | -5 | -0.1% | 84,700 |
| 2022/03/16 | 4,135 | 4,235 | 4,130 | 4,200 | +65 | +1.6% | 97,100 |
| 2022/03/15 | 4,075 | 4,150 | 4,070 | 4,135 | +85 | +2.1% | 59,500 |
| 2022/03/14 | 4,135 | 4,145 | 4,035 | 4,050 | -85 | -2.1% | 67,600 |
751～
800
件表示中 / 3723件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,000円 | -6.4% | -71.8% | 4.92% | 43.11倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 378,000円 | +21.7% | +999.9% | 0.00% | 15.84倍 | 5.24倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 299,900円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
